1. Activation of the cytokine network and unfavorable outcome in patients with yellow fever.
- Author
-
ter Meulen J, Sakho M, Koulemou K, Magassouba N, Bah A, Preiser W, Daffis S, Klewitz C, Bae HG, Niedrig M, Zeller H, Heinzel-Gutenbrunner M, Koivogui L, and Kaufmann A
- Subjects
- Adolescent, Adult, Aged, Chemokine CCL2 blood, Chemokine CXCL10, Chemokines, CXC blood, Child, Child, Preschool, Cytokines immunology, Female, Guinea, Hemorrhage, Humans, Inflammation Mediators immunology, Interleukin 1 Receptor Antagonist Protein, Interleukin-6 blood, Male, Middle Aged, Sialoglycoproteins blood, Tumor Necrosis Factor-alpha analysis, Yellow Fever pathology, Yellow Fever physiopathology, Cytokines blood, Inflammation Mediators blood, Yellow Fever immunology
- Abstract
To study the contribution of inflammatory mediators to the pathogenesis of yellow fever (YF), the serum levels of several cytokines and chemokines were measured in 7 patients with fatal YF (f-YF), 11 patients with nonfatal hemorrhagic YF (nf/h-YF), and 18 patients with nonfatal nonhemorrhagic YF (nf/nh-YF). The levels of interleukin (IL)-6, monocyte chemoattractant protein-1, interferon-inducible protein (IP)-10, tumor necrosis factor- alpha , and IL-1 receptor antagonist (IL-1RA) were all statistically significantly higher in the patients with f-YF than in those with nf/nh-YF. In patients with nf/h-YF, only levels of IP-10 and IL-1RA were significantly elevated. The high levels of pro- and anti-inflammatory cytokines and chemokines in serum from patients with f-YF are reminiscent of those seen in patients with bacterial sepsis. This finding has implications for the understanding of the pathophysiology of YF and the development of therapeutic strategies.
- Published
- 2004
- Full Text
- View/download PDF